• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107-14.

作者信息

Basile Giuseppe, Bandini Marco, Montorsi Francesco, Necchi Andrea

机构信息

Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.

Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.

出版信息

Eur Urol. 2023 Apr;83(4):e111-e112. doi: 10.1016/j.eururo.2023.01.014. Epub 2023 Jan 25.

DOI:10.1016/j.eururo.2023.01.014
PMID:36707359
Abstract
摘要

相似文献

1
Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107-14.对全超、陈金波和胡娇致编辑的信的回复，信中提及朱塞佩·巴西莱、马尔科·班迪尼、尤恩·A·吉布等人的《肌肉浸润性尿路上皮膀胱癌患者新辅助帕博利珠单抗和根治性膀胱切除术：PURE - 01试验的3年中位随访更新》。《临床癌症研究》2022年；28:5107 - 5114。
Eur Urol. 2023 Apr;83(4):e111-e112. doi: 10.1016/j.eururo.2023.01.014. Epub 2023 Jan 25.
2
Re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107-14.回复：朱塞佩·巴西莱、马尔科·班迪尼、尤安·A·吉布等。新辅助帕博利珠单抗与根治性膀胱切除术治疗肌层浸润性尿路上皮膀胱癌患者：PURE - 01试验的3年中位随访更新。《临床癌症研究》2022年；28卷：5107 - 5114页。
Eur Urol. 2023 Apr;83(4):e109-e110. doi: 10.1016/j.eururo.2022.12.035. Epub 2023 Jan 24.
3
Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.回复瓦莱里亚·帕内比安科、弗朗切斯科·德尔·朱迪切、成美典史、朱塞佩·西蒙内、埃托雷·德·贝拉尔迪尼斯及詹姆斯·卡托致编辑的信：关于海伦娜·比利亚 - 雷耶斯、G. 乔尔·德·卡斯特罗及詹姆斯·M. 麦基尔南致编辑的信：关于白云锦、杨宇博及唐寅致编辑的信：关于安德里亚·内奇、马尔科·班迪尼、朱塞平娜·卡莱雷索等人。多参数磁共振成像作为肌肉浸润性膀胱癌新辅助派姆单抗治疗肿瘤反应的无创评估：PURE - 01研究的初步结果。《欧洲泌尿外科杂志》2020年；77卷：636 - 43页。《欧洲泌尿外科杂志》2020年；77卷：e158：多参数磁共振成像能否取代传统的膀胱癌经尿道切除术？《欧洲泌尿外科杂志》2021年；79卷：e35 - e36页。
Eur Urol. 2021 Feb;79(2):e54-e55. doi: 10.1016/j.eururo.2020.11.019. Epub 2020 Nov 26.
4
Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
Eur Urol. 2020 Aug;78(2):e77-e78. doi: 10.1016/j.eururo.2020.04.046. Epub 2020 May 4.
5
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.新辅助帕博利珠单抗联合根治性膀胱切除术治疗肌层浸润性尿路上皮膀胱癌患者：PURE-01 试验 3 年中位随访更新结果。
Clin Cancer Res. 2022 Dec 1;28(23):5107-5114. doi: 10.1158/1078-0432.CCR-22-2158.
6
Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01, Study. Eur Urol 2020;77:636-43.回复白云锦、杨玉波、唐寅致编辑的信，主题：安德里亚·内奇、马尔科·班迪尼、朱塞平娜·卡莱雷索等人。多参数磁共振成像作为肌肉浸润性膀胱癌新辅助派姆单抗治疗肿瘤反应的无创评估：PURE - 01研究的初步结果。《欧洲泌尿外科杂志》2020年；77卷：636 - 43页
Eur Urol. 2020 Jun;77(6):e159-e160. doi: 10.1016/j.eururo.2020.03.009. Epub 2020 Mar 14.
7
Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol 2020;78:489-91: Can Open and Robotic Radical Cystectomy be Considered Equally Effective in 2020?
Eur Urol. 2020 Oct;78(4):492-493. doi: 10.1016/j.eururo.2020.07.006. Epub 2020 Jul 18.
8
Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer?回复：白云锦、杨玉波和唐寅致编辑的信，主题为：安德里亚·内奇、马尔科·班迪尼、朱塞平娜·卡莱雷索等人。多参数磁共振成像作为肌肉浸润性膀胱癌新辅助派姆单抗治疗肿瘤反应的无创评估：PURE - 01研究的初步结果。《欧洲泌尿外科杂志》2020年；77卷：636 - 43页。《欧洲泌尿外科杂志》2020年；77卷：e158：多参数磁共振成像能否取代传统的经尿道膀胱癌切除术？
Eur Urol. 2021 Jan;79(1):e35-e36. doi: 10.1016/j.eururo.2020.08.006. Epub 2020 Aug 20.
9
Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.回复：海伦娜·维拉 - 雷耶斯、G. 乔尔·德卡斯特罗和詹姆斯·M. 麦基尔南致编辑的信，关于：白云金、杨玉波和唐寅致编辑的信，关于：安德里亚·内奇、马尔科·班迪尼、朱塞平娜·卡莱雷索等人。多参数磁共振成像作为肌肉浸润性膀胱癌新辅助派姆单抗治疗肿瘤反应的非侵入性评估：PURE - 01研究的初步结果。《欧洲泌尿外科杂志》2020年；77:636 - 43。《欧洲泌尿外科杂志》2020年；77:e158：多参数磁共振成像能否取代传统的膀胱癌经尿道切除术？《欧洲泌尿外科杂志》2021年；79:e35 - e36。
Eur Urol. 2021 Feb;79(2):e52-e53. doi: 10.1016/j.eururo.2020.11.003. Epub 2020 Nov 28.
10
Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9.回复弗朗切斯科·蒙托尔斯、马尔科·班迪尼和安德里亚·内基致编辑的信，信中涉及弗朗切斯科·索里亚、马尔科·莫斯基尼、大卫·达安德烈亚等人的《机器人辅助与开放性根治性膀胱切除术围手术期结果的比较有效性：一项多中心当代回顾性队列研究的结果》。《欧洲泌尿外科聚焦》2020年；6：1233 - 9。
Eur Urol Focus. 2022 Mar;8(2):633-634. doi: 10.1016/j.euf.2021.04.002. Epub 2021 Apr 17.